Influenza Therapeutic Landscape - isirv Home · 2018. 12. 5. · CR6261 mAb Grp 1 CT-P27 2 mAbs...
1
Flufivitide-3 HA inhibitor Radavirsen Equine Polyclonal H5 Xofluza Baloxavir TCN-032 mAb M2e TCAD Combo Pimodivir PB2 inhibitor CR6261 mAb Grp 1 CT-P27 2 mAbs VIS-410 mAb Favipiravir Flumadine (Rimantadine ) Symmetrel (Amantadine) Inavir Laninamivir (Japan only) Tamiflu oseltamivir Relenza zanamivir Rapivab peramivir GP1001 (ImmMod) PUR003 Alferon LDO INF-αn3 FLUDASE Nitazoxanide Phase 1 Phase 2 Phase 3 Market Viral Targets Host Targets Verdinexor High titer influenza immune plasma Celecoxi b Atorvastatin IVIg H1N1/H3N2 Flufenamic acid (FFA) KT07 herb mix Etilefrine Diltiazem PA Inhibitor M2 Inhibitors NAIs Influenza Therapeutic Landscape Other Inhaled IV Oral Apomivir XC221 ZSP1273
Transcript of Influenza Therapeutic Landscape - isirv Home · 2018. 12. 5. · CR6261 mAb Grp 1 CT-P27 2 mAbs...
-
Flufivitide-3
HA inhibitor
RadavirsenEquine
Polyclonal H5
Xofluza
Baloxavir
TCN-032
mAb M2e
TCAD
Combo
Pimodivir
PB2 inhibitor
CR6261
mAb Grp 1CT-P27
2 mAbs
VIS-410
mAb
FavipiravirFlumadine
(Rimantadine
)
Symmetrel
(Amantadine)
Inavir
Laninamivir
(Japan only)
Tamiflu
oseltamivir
Relenza
zanamivir
Rapivab
peramivir
GP1001
(ImmMod)PUR003 Alferon LDO
INF-αn3
FLUDASENitazoxanide
Phase 1 Phase 2 Phase 3 Market
Vir
al T
arge
tsH
ost
Tar
gets
Verdinexor
High titer
influenza
immune plasma
Celecoxi
b
Atorvastatin
IVIgH1N1/H3N2
Flufenamic
acid (FFA)KT07
herb mix
Etilefrine
Diltiazem
PA Inhibitor
M2 Inhibitors NAIs
Influenza Therapeutic Landscape
Other
Inhaled
IV
Oral
Apomivir
XC221
ZSP1273